These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21476968)

  • 1. Functional relevance of biased signaling at the angiotensin II type 1 receptor.
    Tilley DG
    Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):99-111. PubMed ID: 21476968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.
    Takezako T; Unal H; Karnik SS; Node K
    Pharmacol Res; 2017 Sep; 123():40-50. PubMed ID: 28648738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
    Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
    J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signaling.
    Lymperopoulos A; Borges JI; Carbone AM; Cora N; Sizova A
    Pharmacol Res; 2021 Dec; 174():105943. PubMed ID: 34662735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.
    Ferraino KE; Cora N; Pollard CM; Sizova A; Maning J; Lymperopoulos A
    Cell Signal; 2021 Jun; 82():109967. PubMed ID: 33640432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-molecule force spectroscopy study of interactions between angiotensin II type 1 receptor and different biased ligands in living cells.
    Li W; Xu J; Kou X; Zhao R; Zhou W; Fang X
    Anal Bioanal Chem; 2018 May; 410(14):3275-3284. PubMed ID: 29492619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biased agonism of the angiotensin II type 1 receptor.
    Godin CM; Ferguson SS
    Mini Rev Med Chem; 2012 Aug; 12(9):812-6. PubMed ID: 22681254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biased Agonism of the Angiotensin II Type I Receptor.
    Ikeda Y; Kumagai H; Motozawa Y; Suzuki J; Komuro I
    Int Heart J; 2015; 56(5):485-8. PubMed ID: 26180022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanoactivation of the angiotensin II type 1 receptor induces β-arrestin-biased signaling through Gα
    Wang J; Hanada K; Gareri C; Rockman HA
    J Cell Biochem; 2018 Apr; 119(4):3586-3597. PubMed ID: 29231251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Arrestin mediates the Frank-Starling mechanism of cardiac contractility.
    Abraham DM; Davis RT; Warren CM; Mao L; Wolska BM; Solaro RJ; Rockman HA
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14426-14431. PubMed ID: 27911784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mechanisms of G-protein-coupled receptors functions: AT
    Tóth AD; Turu G; Hunyady L; Balla A
    Best Pract Res Clin Endocrinol Metab; 2018 Apr; 32(2):69-82. PubMed ID: 29678287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping Angiotensin II Type 1 Receptor-Biased Signaling Using Proximity Labeling and Proteomics Identifies Diverse Actions of Biased Agonists.
    Pfeiffer CT; Wang J; Paulo JA; Jiang X; Gygi SP; Rockman HA
    J Proteome Res; 2021 Jun; 20(6):3256-3267. PubMed ID: 33950683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II cyclic analogs as tools to investigate AT
    St-Pierre D; Cabana J; Holleran BJ; Besserer-Offroy É; Escher E; Guillemette G; Lavigne P; Leduc R
    Biochem Pharmacol; 2018 Aug; 154():104-117. PubMed ID: 29684376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.
    Zimmerman B; Beautrait A; Aguila B; Charles R; Escher E; Claing A; Bouvier M; Laporte SA
    Sci Signal; 2012 Apr; 5(221):ra33. PubMed ID: 22534132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent transducer-specific molecular efficacies generate biased agonism at a G protein-coupled receptor (GPCR).
    Strachan RT; Sun JP; Rominger DH; Violin JD; Ahn S; Rojas Bie Thomsen A; Zhu X; Kleist A; Costa T; Lefkowitz RJ
    J Biol Chem; 2014 May; 289(20):14211-24. PubMed ID: 24668815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
    Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressor meets vasodepressor: The AT1-B2 receptor heterodimer.
    Quitterer U; AbdAlla S
    Biochem Pharmacol; 2014 Apr; 88(3):284-90. PubMed ID: 24462918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-arrestins in the context of cardiovascular diseases: Focusing on angiotensin II type 1 receptor (AT1R).
    Lino CA; Barreto-Chaves ML
    Cell Signal; 2022 Apr; 92():110253. PubMed ID: 35077849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury.
    Kim KS; Abraham D; Williams B; Violin JD; Mao L; Rockman HA
    Am J Physiol Heart Circ Physiol; 2012 Oct; 303(8):H1001-10. PubMed ID: 22886417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biased agonism/antagonism at the AngII-AT1 receptor: Implications for adrenal aldosterone production and cardiovascular therapy.
    Maning J; Negussie S; Clark MA; Lymperopoulos A
    Pharmacol Res; 2017 Nov; 125(Pt A):14-20. PubMed ID: 28511989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.